The use of dopamine agonists in very elderly patients with Parkinson's disease

被引：0
|
作者：
Shulman, LM
Minagar, A
Rabinstein, A
Weiner, WJ
机构：
来源：
ANNALS OF NEUROLOGY | 1999年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：497 / 498
页数：2
相关论文
共 50 条
  • [1] The use of dopamine agonists in very elderly patients with Parkinson's disease
    Shulman, LM
    Minagar, A
    Rabinstein, A
    Weiner, WJ
    MOVEMENT DISORDERS, 2000, 15 (04) : 664 - 668
  • [2] Use of dopamine agonists in aged patients with Parkinson's disease
    Fabbrini, G
    Barbanti, P
    Aurilia, C
    Pauletti, C
    Vanacore, N
    Meco, G
    MOVEMENT DISORDERS, 2002, 17 : S73 - S73
  • [3] The use of dopamine agonists in aging patients with Parkinson's disease
    Shulman, LM
    Weiner, WH
    Minagar, A
    Rabinstein, A
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 466 - 466
  • [4] Optimizing the use of dopamine agonists in Parkinson's disease
    Olanow, C. Warren
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 316 - 316
  • [5] The use of dopamine agonists in Parkinson's disease treatment
    Gekht, AB
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2002, 102 (09): : 54 - 58
  • [6] WITHDRAWAL OF DOPAMINE AGONISTS IN PATIENTS WITH PARKINSON'S DISEASE
    Cunnington, A-L
    Hood, K.
    White, L.
    AGE AND AGEING, 2011, 40 : II63 - II63
  • [7] Valvular heart disease and the use of dopamine agonists for Parkinson's disease
    Zanettini, Renzo
    Antonini, Angelo
    Gatto, Gemma
    Gentile, Rosa
    Tesei, Silvana
    Pezzoli, Gianni
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01): : 39 - 46
  • [8] Parkinson’s disease: The proper use of dopamine receptor agonists
    Lisa M. Shulman
    Current Treatment Options in Neurology, 1999, 1 (1) : 14 - 20
  • [9] Dopamine agonists for Parkinson's disease
    Sharma, J
    MacMahon, D
    Stewart, D
    LANCET, 2003, 361 (9351): : 84 - 84
  • [10] Dopamine agonists in Parkinson's disease
    Tintner, R
    Jankovic, J
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (11) : 1803 - 1820
12345